Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma

被引：0
|
作者：
Shozo Mori
Taku Aoki
Yuhki Sakuraoka
Takayuki Shimizu
Takamune Yamaguchi
Kyung-Hwa Park
Takatsugu Matsumoto
Takayuki Shiraki
Yukihiro Iso
Keiichi Kubota
机构：
[1] Dokkyo Medical University,Department of Gastroenterological Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Pancreatic cancer; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Gemcitabine; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 120
页数：11
相关论文
共 50 条
  • [1] Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma
    Mori, Shozo
    Aoki, Taku
    Sakuraoka, Yuhki
    Shimizu, Takayuki
    Yamaguchi, Takamune
    Park, Kyung-Hwa
    Matsumoto, Takatsugu
    Shiraki, Takayuki
    Iso, Yukihiro
    Kubota, Keiichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 109 - 120
  • [2] Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
    Leonhardt Carl S.
    Traub Benno
    Hackert Thilo
    Klaiber Ulla
    Strobel Oliver
    Büchler Markus W.
    Neoptolemos John P.
    Department of General
    Department of Surgery
    胰腺病学杂志（英文）, 2020, 03 (01) : 1 - 11
  • [3] Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma
    Brown, Zachary J.
    Labiner, Hanna E.
    Shen, Chengli
    Ejaz, Aslam
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (02) : 185 - 193
  • [4] Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
    Wysocka, Olga
    Kulbacka, Julita
    Saczko, Jolanta
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2016, 11 (03): : 155 - 162
  • [5] The Role of Radiation Therapy in Pancreatic Ductal Adenocarcinoma in the Neoadjuvant and Adjuvant Settings
    Franke, Aaron J.
    Rosati, Lauren M.
    Pawlik, Timothy M.
    Kumar, Rachit
    Herman, Joseph M.
    SEMINARS IN ONCOLOGY, 2015, 42 (01) : 144 - 162
  • [6] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [7] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    Annals of Surgical Oncology, 2014, 21 : 670 - 676
  • [8] Neoadjuvant and Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma: Does Drug Selection, Duration, or Sequence Affect Outcomes?
    Javed, A.
    Burkhart, R.
    Ronnekleiv-Kelly, S.
    Hasanain, A.
    Rosati, L. M.
    He, J.
    Makary, M.
    Laheru, D. A.
    Hruban, R. H.
    Zheng, L.
    Herman, J. M.
    Cameron, J.
    Wolfgang, C.
    Weiss, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S105 - S105
  • [9] Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
    Ei, Shigenori
    Takahashi, Shinichiro
    Ogasawara, Toshihito
    Mashiko, Taro
    Masuoka, Yoshihito
    Nakagohri, Toshio
    GUT AND LIVER, 2023, 17 (05) : 698 - 710
  • [10] Pharmacological Ascorbate Enhances Chemotherapies in Pancreatic Ductal Adenocarcinoma
    O'Leary, Brianne R.
    Ruppenkamp, Elena K.
    Steers, Garett J.
    Du, Juan
    Carroll, Rory S.
    Wagner, Brett A.
    Buettner, Garry R.
    Cullen, Joseph J.
    PANCREAS, 2022, 51 (06) : 684 - 693
12345